TORONTO, March 30, 2021 /CNW/ – NEW WAVE HOLDINGS CORP. (the “Company” or “New Wave”) (CSE: SPOR) (FWB: 0XM2) (OTCPK: TRMNF) an
investment issuer that provides capital and support services, is pleased to announce the successful completion of their production staff training last week as part of the company’s larger plan to
obtaining their GMP certification.
In the wake of its recent facility expansion, as well as the strategic collaboration with e-commerce optimization experts N2 Logics, Way of Will has been making leaps in their progress toward
expanding their market presence in Canada as well as online. Now, the rapidly growing health and wellness brand has set their sights on becoming GMP certified. This
month, the production team successfully completed training in Good Manufacturing Practices led by Mr. Iman Navab, the founder of Dynamise and a member of New Wave’s
scientific advisory board.
The GMP (Good Manufacturing Practices) certification is a widely recognized accreditation that verifies a manufacturer’s dedication and commitment to adhering to international GMP standards. While
Way of Will’s production staff has always been compliant with GMP standards, officially obtaining the certification will increase the brand’s credibility as they uphold an internationally recognized
manufacturing standard. Companies that are GMP certified instill greater confidence in their customers, as the products are manufactured in compliance with the highest manufacturing standards to
ensure product safety and quality.
Production staff and supervisors were trained to implement Standard Operation Procedures and Good Manufacturing Practices related to their roles and responsibilities within the production
department, which included the following:
- Facilities Sanitation Program
- Equipment and Utensils Sanitation Program
- Product Specifications Recordings
- QC Sampling and Testing
- Equipment
Maintenance - Good Hygiene Practices (e.g., safe handling of materials to prevent cross-contamination)
- Receipt and Control of Materials
- Good Documentation
Practices
“We’re extremely pleased that our production team has received this critical training to get us one step closer to acquiring our GMP certification,” commented Willie Tsang, founder and CEO of Way of Will. “With the significant growth—of both our facility here and our online sales—that the company has witnessed in the recent
months, it is crucial that we work even harder to keep up with the progress. I have the utmost confidence in our team, who is guided by strong leaders and who is well-equipped to excel at whatever
goals we set our sights on. We will continue supporting our staff and providing the necessary resources to elevate our team to the next level.”
ABOUT NEW WAVE HOLDINGS CORP.
New Wave Holdings Corp. (CSE: SPOR, FWB: 0XM2, OTCPK: TRMNF) is an investment issuer focused on the burgeoning nutraceutical and psychedelic sector and support for adaptive and progressive health
and wellness products and therapies. New Wave subsidiaries contain various health and beauty products within its portfolio of non-psychoactive plants and fungi as it continues to expand its product
distribution through vertical integration to provide end to end solutions while capturing a high margin business model.
Investors interested in connecting with New Wave Holdings can learn more about the company and contact the team at http://newwavecorp.com.
Information relating to WAY OF WILL INC., contained in this news release was provided by WAY OF WILL INC. and/or its agent and has not been independently verified by the Company. The Company does
not take responsibility for the accuracy of such information.
The CSE has not in any way passed on the merits of the Acquisition, and neither has approved nor disapproved the contents of this press release. Neither the CSE nor its Market Regulator (as that
term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
FORWARD-LOOKING INFORMATION DISCLAIMER
Certain statements contained in this news release may constitute forward–looking information, including but not limited to, applicable regulatory approval in connection with the Acquisition, the
closing of the Acquisition, expansion of operations, size and quality of future tournaments and projections regarding attendance at future events. Forward–looking information is often, but not
always, identified by the use of words such as “anticipate”, “plan”, “estimate”, “expect”, “may”, “will”, “intend”, “should”, and similar expressions. Forward–looking information involves known and
unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward–looking information. The Company’s actual results
could differ materially from those anticipated in this forward–looking information as a result of competitive factors and competition for investment opportunities, challenges relating to operations
in international markets, transaction execution risk, changes to the Company’s strategic growth plans, and other factors, many of which are beyond the control of the Company. The Company believes
that the expectations reflected in the forward–looking information are reasonable based on current expectations and potential investment pipeline, but no assurance can be given that these
expectations will prove to be correct and such forward–looking information should not be unduly relied upon. Any forward–looking information contained in this news release represents the
Company’s expectations as of the date hereof and is subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward–looking information whether
as a result of new information, future events or otherwise, except as required by applicable securities legislation.
Learn more about the psychedelics industry at Microdose.